UnitedHealth Group (NYSE:UNH) is a leading health insurance provider in the United States, operating in the Zacks Medical - HMOs industry. The company offers a wide range of health care products and insurance services. UnitedHealth competes with other major players in the industry, such as Anthem and Cigna, striving to maintain its position as a top health insurer.
On October 28, 2025, UnitedHealth reported earnings per share (EPS) of $2.92, surpassing the estimated $2.80. This performance also exceeded the Zacks Consensus Estimate of $2.75, marking a significant earnings surprise of 6.18%. Despite this positive surprise, the EPS decreased from $7.15 in the same quarter last year, indicating a decline in profitability.
UnitedHealth's revenue for the quarter was $113.161 billion, slightly above the estimated $113.028 billion. However, it fell short of the Zacks Consensus Estimate by 0.17%. This revenue represents a substantial increase from the $100.82 billion reported a year ago, highlighting the company's growth efforts. The company has only surpassed consensus revenue estimates once in the last four quarters.
The company's financial metrics provide further insight into its performance. UnitedHealth has a price-to-earnings (P/E) ratio of approximately 14.24, reflecting investor expectations for future earnings growth. The price-to-sales ratio is about 0.76, indicating the market's valuation of its sales. The enterprise value to sales ratio is around 0.71, showing the company's total valuation relative to its sales.
UnitedHealth's current ratio is approximately 0.82, suggesting its ability to cover short-term liabilities with short-term assets. The earnings yield is about 7.02%, offering a perspective on the return on investment. The enterprise value to operating cash flow ratio is approximately 14.72, providing insight into the company's cash flow efficiency. These metrics highlight UnitedHealth's financial health and operational efficiency.
